ALEBUND-B (09637) Spends About HK$115,400 to Buy Back 6,600 Shares on November 5

Private Fund October Research Insights: Electronics and Pharmaceuticals Dominate as Gaoyi, Springs Capital, and Juming Capital Make Frequent Appearances; Yuanjie Semiconductor and Victory Giant Technology Draw the Most Attention

Dizal Pharmaceutical's Blood Cancer Pipeline Achieves Multiple ASH Annual Meeting Selections

Pharma Stocks Keep Soaring! 520880's Benchmark Index Touches 5%, CSI Medical Index Climbs 3% for Fifth Straight Gain! Is the Main Uptrend Beginning? Fund Manager Weighs In

Pharma Stocks Extend Afternoon Gains as SBP Group Jumps Over 7% and BeOne Medicines Rises More Than 6%

Hong Kong Stocks on the Move: Pharma Shares Extend Rally as SBP Group Leads Gains with US$7 Billion BD Deal; First Three Quarters of Outbound Licensing Nearly Match Full-Year Total

China Universal Asset Management Raises Stake in GenFleet Therapeutics-B with Purchase of 299,600 Shares at HK$23.44 Each

GENFLEET-B (02595) Jumps Nearly 5% in Early Trading as GFH276 Gains Clinical Approvals for Multiple Innovative Combination Therapies

CKLIFE SCIENCES' Sequencio Therapeutics to Present Latest Preclinical Data on Two Cancer Vaccines at SITC 2026 Annual Meeting

GenFleet-B (02595): Oral Pan-RAS Inhibitor GFH276 Gains Multiple Clinical Trial Approvals for Combination Therapies in China and Overseas

AleBund-B (09637) Fires First Shot in HK$100 Million Buyback Plan with Nearly HK$1 Million Repurchase

China Resources Double-Crane Pharmaceutical's Subsidiary Zhongshuai Pharma Passes Drug GMP Compliance Inspection

GenFleet-B Spends Around HK$12.9713 Million to Repurchase 560,000 Shares on October 30

Dizal Pharmaceutical Reports Stellar First Three Quarters Results with Net Profit Attributable to Shareholders of 3.639 Billion Yuan

Medical Stocks Surge After Earnings as Andon Health Hits Limit Up, Healthcare ETF Rises Against the Trend

CMS: Q3 Public Fund Holdings Rebalanced — Cutting High-Flying Tech, Adding Pharma, Consumer and Dividend Sectors

GENFLEET-B (02595) Spends Approximately HK$1.7427 Million to Repurchase 65,000 Shares on October 28

FANGZHOU JIANKE Shares Jump Over 10% Intraday as Company Case Selected for 2026 Pharmaceutical Distribution High-Quality Development Best Practices

Hong Kong Stock Movement: Alebund-B (09637) Surges Over 10% in Early Trading as Partner R1 Presents AP306 Global Phase IIb Multi-Regional Clinical Trial Design Poster at ASN Kidney Week

After-Hours Market Highlights: 440-Billion-Yuan Pharma Giant Lifts Guidance, Multiple Leaders Post Sharp Profit Gains